BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Biosimilars
Artificial intelligence
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Wednesday, April 17, 2024
Home
»
Newsletters
» BioWorld
BioWorld
Aug. 30, 2010
View Archived Issues
Genentech Caught off Guard, FDA Issues Refuse-to-File for T-DM1
The FDA sent a refuse-to-file letter to Genentech Inc., a member of the Roche Group, rejecting the company's application for accelerated approval of trastuzumab-DM1 (T-DM1) and catching investors and the company off guard. (BioWorld Today)
Read More
Otonomy Lures New Investors with $38.5M Series B Financing
Read More
Senate to Hold Hearing on Funding for Stem Cells
Read More
FDA Oversteps its Bounds for Jazz Fibromyalgia Drug
Read More
Genzyme's ERT Rationing to End Soon; Sanofi Still Biting?
Read More
Corrections & Clarifications
Read More
Clinic Roundup
Read More
Stock Movers
Read More
Financings Roundup
Read More
Other News To Note
Read More
U.S. Patent Disclosures
Read More
Bench Press
Read More